Friday, 20 April 2018 - 21:12
  • it
  • de
  • en
  • fr

Tigenix

First large acquisition of the year: Takeda acquires Tigenix for €520m

Belgian-Spanish biotech company TiGenix NV and Takeda Pharmaceutical have jointly announced today, before trading opened, that Takeda is planning to purchase all TiGenix shares at €1.79 per share, which means setting TiGenix’s value at approximately €520m. TiGenix’s key asset is…